Human immunodeficiency virus type 1 Vpu modifies viral cytopathic effect through augmented virus release. 1997

Y Iwatani, and S K Song, and L Wang, and J Planas, and H Sakai, and A Ishimoto, and M W Cloyd
Institute for Virus Research, Kyoto University, Japan.

We characterized two human immunodeficiency virus type 1 (HIV-1) strains, HIVMCK and HIV213, which have different cytopathic effects in infected cells. HIV213 was highly cytopathic, whereas HIVMCK was not. Biological analyses of chimeric viruses from the cloned infectious DNAs of HIVMCK and HIV213 showed that the Vpu region was responsible for the differing cytopathicity of these viruses. Although HIVMCK expressed Vpu protein, HIV213 did not because of a mutation at the start codon for Vpu. The amounts of envelope glycoprotein and virus particles associated with the cell surface were significantly increased on cells infected with Vpu-deficient viruses compared with Vpu-positive viruses. These data suggest that the highly cytopathic effects of HIV213 (Vpu-deficient) are due to an accumulation of envelope glycoprotein at the infected-cell surface, which would be caused by the retention of progeny virions in the absence of Vpu-facilitated virion release.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016865 Reassortant Viruses Viruses containing two or more pieces of nucleic acid (segmented genome) from different parents. Such viruses are produced in cells coinfected with different strains of a given virus. Reassortant Virus,Virus, Reassortant,Viruses, Reassortant
D054298 Human Immunodeficiency Virus Proteins Proteins synthesized by HUMAN IMMUNODEFICIENCY VIRUSES such as the HIV-1 and HIV-2. HIV Proteins,HIV Gene Products,Human Immunodeficiency Virus Gene Products

Related Publications

Y Iwatani, and S K Song, and L Wang, and J Planas, and H Sakai, and A Ishimoto, and M W Cloyd
July 1989, Proceedings of the National Academy of Sciences of the United States of America,
Y Iwatani, and S K Song, and L Wang, and J Planas, and H Sakai, and A Ishimoto, and M W Cloyd
January 1995, Current topics in microbiology and immunology,
Y Iwatani, and S K Song, and L Wang, and J Planas, and H Sakai, and A Ishimoto, and M W Cloyd
February 1996, Journal of virology,
Y Iwatani, and S K Song, and L Wang, and J Planas, and H Sakai, and A Ishimoto, and M W Cloyd
February 1990, Journal of virology,
Y Iwatani, and S K Song, and L Wang, and J Planas, and H Sakai, and A Ishimoto, and M W Cloyd
July 2001, Journal of virology,
Y Iwatani, and S K Song, and L Wang, and J Planas, and H Sakai, and A Ishimoto, and M W Cloyd
September 1998, Biochemistry,
Y Iwatani, and S K Song, and L Wang, and J Planas, and H Sakai, and A Ishimoto, and M W Cloyd
December 2010, Virology,
Y Iwatani, and S K Song, and L Wang, and J Planas, and H Sakai, and A Ishimoto, and M W Cloyd
April 2002, Chemical & pharmaceutical bulletin,
Y Iwatani, and S K Song, and L Wang, and J Planas, and H Sakai, and A Ishimoto, and M W Cloyd
January 1992, The Journal of general virology,
Y Iwatani, and S K Song, and L Wang, and J Planas, and H Sakai, and A Ishimoto, and M W Cloyd
September 1989, Journal of virology,
Copied contents to your clipboard!